NZM2328: a new mouse model of systemic lupus erythematosus with unique genetic susceptibility loci.
about
Anti-dsDNA Antibodies are one of the many autoantibodies in systemic lupus erythematosusRole of type I interferons in the activation of autoreactive B cellsModelling clinical systemic lupus erythematosus: similarities, differences and success storiesPodocyte Activation of NLRP3 Inflammasomes Contributes to the Development of Proteinuria in Lupus Nephritis.Pathogenesis of proliferative lupus nephritis from a historical and personal perspective.A Central Role for HLA-DR3 in Anti-Smith Antibody Responses and Glomerulonephritis in a Transgenic Mouse Model of Spontaneous LupusGenetics of systemic lupus erythematosus: immune responses and end organ resistance to damage.Autoantibodies and glomerulonephritis in systemic lupus erythematosus.Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis.P2X7 blockade attenuates murine lupus nephritis by inhibiting activation of the NLRP3/ASC/caspase 1 pathway.Interferon alpha on NZM2328.Lc1R27: enhancing autoimmunity and immune complex-mediated glomerulonephritis without end stage renal failureCgnz1 allele confers kidney resistance to damage preventing progression of immune complex-mediated acute lupus glomerulonephritis.Autoimmunity, end organ damage, and the origin of autoantibodies and autoreactive T cells in systemic lupus erythematosus.Pathogenesis of systemic lupus erythematosus revisited 2011: end organ resistance to damage, autoantibody initiation and diversification, and HLA-DR.Natural killer cells regulate murine cytomegalovirus-induced sialadenitis and salivary gland disease.Novel therapeutic approaches to lupus glomerulonephritis: translating animal models to clinical practice.Differential responses to Smith D autoantigen by mice with HLA-DR and HLA-DQ transgenes: dominant responses by HLA-DR3 transgenic mice with diversification of autoantibodies to small nuclear ribonucleoprotein, double-stranded DNA, and nuclear antigeLupus glomerulonephritis revisited 2004: autoimmunity and end-organ damage.Pathogenesis of kidney disease in systemic lupus erythematosus.Genetic complementation results in augmented autoantibody responses to lupus-associated antigens.Anti-alpha8 integrin immunoliposomes in glomeruli of lupus-susceptible mice: a novel system for delivery of therapeutic agents to the renal glomerulus in systemic lupus erythematosus.Genetic approach to study lupus glomerulonephritis.NKG2D+CD4+ T Cells Kill Regulatory T Cells in a NKG2D-NKG2D Ligand- Dependent Manner in Systemic Lupus Erythematosus.Paucity of clinical disease despite serological autoimmunity and kidney pathology in lupus-prone New Zealand mixed 2328 mice deficient in BAFFMurine lupus susceptibility locus Sle1a requires the expression of two sub-loci to induce inflammatory T cellsMurine models of systemic lupus erythematosusB Cell and BAFF dependence of IFN-α-exaggerated disease in systemic lupus erythematosus-prone NZM 2328 mice.Accelerated pathological and clinical nephritis in systemic lupus erythematosus-prone New Zealand Mixed 2328 mice doubly deficient in TNF receptor 1 and TNF receptor 2 via a Th17-associated pathwayThe XX sex chromosome complement in mice is associated with increased spontaneous lupus compared with XY.Role of MHC-linked susceptibility genes in the pathogenesis of human and murine lupus.Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosisVaccination with minigenes encoding V(H)-derived major histocompatibility complex class I-binding epitopes activates cytotoxic T cells that ablate autoantibody-producing B cells and inhibit lupus.A female preponderance for chemically induced lupus in SJL/J mice.TGF-β-Induced Regulatory T Cells Directly Suppress B Cell Responses through a Noncytotoxic MechanismPeptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupusDeficiency of type I IFN receptor in lupus-prone New Zealand mixed 2328 mice decreases dendritic cell numbers and activation and protects from disease.Cellular and molecular pathogenesis of systemic lupus erythematosus: lessons from animal models.TLR7 and TLR9 in SLE: when sensing self goes wrong.Molecular and Immunological Basis of Tubulo-Interstitial Injury in Lupus Nephritis: a Comprehensive Review.An update on lupus animal models.
P2860
Q26776493-60855D47-2DA7-49CD-B5FF-47E1CE245F15Q26858821-0E933935-9CFB-4812-B44B-7486358BCDFBQ28074217-3CF7396E-5776-4D46-B16D-28A8A8D4B581Q30252343-8E09BFDE-E859-44B6-BCB9-D37F8A81BD45Q30275634-E02A2E49-A5E0-447B-A559-10BE0DD2146FQ30278514-962AC62C-B9E4-4747-AA29-842044374504Q30301191-B907355D-AC71-4C0D-A820-05B6ABD04E0DQ30310795-27E0783D-F73E-4804-A74E-95ECE4E7B3D0Q30312212-82090051-3B55-41AA-A5DC-468573E5254FQ30409205-31BA057E-3E22-4829-B16D-272EC38A2BBFQ30410652-CF71E821-C0B9-4051-A31C-96DEEF5C81FEQ30413753-B61E2695-316A-4BE4-BC3F-ED47D7A51842Q30418064-F6309808-BBC6-4956-AEF8-EC6E87F5A806Q30425180-38B39DF0-CC80-4D38-83E0-586BD317CABCQ30425772-5FEA4B10-6A69-488B-A931-9A2728E77E47Q30427986-74D7912F-8935-4896-9D3D-9E90E70A2646Q30433491-5FC41CE3-B66E-4983-90A8-0941BE632BC2Q30433903-EA58B037-E639-4836-B27C-53AEAC620CB6Q30434907-D82FF75C-F7EC-42A8-8503-7723141E1322Q30434941-307058D2-5475-47F0-858B-B7C9F0E675F0Q30437707-FB998A55-E26E-4537-8A80-52EACD1822F0Q30456024-3FD97184-8520-473E-B751-19B562672E0FQ33682274-7B998076-92F8-4634-8FDA-DDAED686C813Q33960050-F94CD4B4-8A5B-4D61-B51D-0F39FF3C6306Q34217717-8B1996EE-186A-41BA-A677-75CF4A8E43D0Q34591019-1B751E50-C081-4664-ABD5-FEB3039D6B5BQ34781487-BFBA8826-F2C5-4535-9149-ED36CC8DCE7EQ34939962-14D93F00-AFA8-4CEE-9CE9-0FB62F32AB56Q35674459-3761901C-5CAB-43AC-AFA8-571A53CDF5A4Q36065912-9EDD36F7-848F-4559-BC7F-0F9E159E2AE0Q36139902-BA208D69-FF94-408F-BBD6-2F36BBB6C327Q36371233-548F0040-7EDC-4707-BFFA-74752B7BFD3BQ36536962-A25BB077-5FEA-45CA-8D6B-0B6DA5C087E5Q36905992-F0F0B52F-B8AE-41A5-9696-7974811A0E12Q36966870-4934B3D3-D93C-4F23-BB93-D48B9CDB045BQ37396863-A8690BB8-6DCB-4D8B-85B9-5A357204FB9FQ37944412-82442D9A-37C3-438A-B4F1-C5B4111F17B2Q37995556-BF05CACB-1DFC-48B1-9004-DD914543B2F1Q38767584-B8CB2B34-0A6D-420C-B435-F423BC1F7C0EQ39326265-1160B41D-4F85-4144-A721-59111723AF61
P2860
NZM2328: a new mouse model of systemic lupus erythematosus with unique genetic susceptibility loci.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
NZM2328: a new mouse model of ...... e genetic susceptibility loci.
@ast
NZM2328: a new mouse model of ...... e genetic susceptibility loci.
@en
type
label
NZM2328: a new mouse model of ...... e genetic susceptibility loci.
@ast
NZM2328: a new mouse model of ...... e genetic susceptibility loci.
@en
prefLabel
NZM2328: a new mouse model of ...... e genetic susceptibility loci.
@ast
NZM2328: a new mouse model of ...... e genetic susceptibility loci.
@en
P2093
P356
P1433
P1476
NZM2328: a new mouse model of ...... e genetic susceptibility loci.
@en
P2093
Deshmukh US
Kannapell CC
McDuffie M
P304
P356
10.1006/CLIM.2001.5079
P577
2001-09-01T00:00:00Z